Production (Stage)
D
Amphastar Pharmaceuticals, Inc. AMPH
$25.53 $1.064.33% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -8.44% 15.98% 16.58% 63.34% 66.04%
Total Depreciation and Amortization 20.90% 36.93% 59.51% 90.82% 67.42%
Total Amortization of Deferred Charges -65.35% -47.08% -3.46% 260.89% 2,465.33%
Total Other Non-Cash Items -5.76% -69.53% 167.19% 5.18% 135.00%
Change in Net Operating Assets 23.28% 39.91% -190.99% -154.99% 36.66%
Cash from Operations -2.64% 16.28% 19.08% 62.41% 151.80%
Capital Expenditure -14.57% -7.53% -8.67% -13.16% -36.94%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 74.53% 74.53% 74.53% 73.13% --
Divestitures -- -- -- -- --
Other Investing Activities 150.51% 143.15% -419.54% -2,324.24% -2,643.78%
Cash from Investing 79.33% 80.75% 64.80% 64.39% -1,991.82%
Total Debt Issued -98.12% -97.82% -98.39% -30.19% --
Total Debt Repaid 97.42% 97.41% 78.30% -273.95% -14,273.04%
Issuance of Common Stock -- -- -74.37% -56.80% 67.13%
Repurchase of Common Stock -31.75% -44.30% 35.91% -55.05% -31.31%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 96.11% 96.75% 94.60% 22.73% -6,479.48%
Cash from Financing -118.03% -117.83% -119.42% -96.04% 1,117.28%
Foreign Exchange rate Adjustments 106.33% 32.62% -1,568.00% -355.81% -125.71%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -174.86% 161.96% -169.29% 355.25% 515.17%